• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

37.40 UNCHANGED
Delayed Quote Updated: 7:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 238,174
Open 37.40
Bid (Size) 37.46 (200)
Ask (Size) 37.47 (200)
Prev. Close 37.40
Today's Range 37.40 - 37.40
52wk Range 35.12 - 64.16
Shares Outstanding N/A
Dividend Yield 3.10%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy ↗
September 30, 2026
Could this be what Novo needs to turn things around? 
Via The Motley Fool
Topics Initial Public Offering
News headline image
Viking Therapeutics Stock Soars 36% on Weight-Loss Drug Data. Why It's Not Too Late to Buy the Stock. ↗
September 30, 2026
There could be more catalysts for the biotech over the next 18 months. 
Via The Motley Fool

Performance

YTD
-28.6%
-28.6%
1 Month
-17.1%
-17.1%
3 Month
-25.8%
-25.8%
6 Month
+1.1%
+1.1%
1 Year
-36.8%
-36.8%

More News

Read More
News headline image
3 Emerging Biotech Stocks With Significant Upside Potential ↗
September 30, 2026
Via MarketBeat
Topics Intellectual Property
News headline image
4 Stocks That Could Split Next—and Why Investors Are Watching ↗
September 30, 2026
Via MarketBeat
Topics Artificial Intelligence
News headline image
Novo Nordisk Gives Uninspiring Outlook ↗
September 29, 2026
Via The Motley Fool
News headline image
Opinion: Eli Lilly Stock Is a No-Brainer Pick to Buy on the Dip ↗
September 29, 2026
Via The Motley Fool
News headline image
Eli Lilly Just Announced Game-Changing News ↗
September 28, 2026
Via The Motley Fool
News headline image
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 27, 2026
Via The Motley Fool
News headline image
Here's Where Wall Street Analysts See Eli Lilly's Share Price Going ↗
September 26, 2026
Via The Motley Fool
News headline image
Lilly Cut an Obesity Drug -- but the Move Shows How High Its Bar Has Become ↗
September 26, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product? ↗
September 25, 2026
Via The Motley Fool
News headline image
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? ↗
September 24, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Viking's Obesity Edge May Be Staying Power, Not Weight Loss ↗
September 23, 2026
Via MarketBeat
News headline image
Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up? ↗
September 23, 2026
Via MarketBeat
Topics Intellectual Property Lawsuit
News headline image
Why Viking Therapeutics Stock Skyrocketed on Tuesday ↗
September 23, 2026
Via The Motley Fool
News headline image
Novo Nordisk Has a Fresh New Name -- but It Still Faces the Same Old Problems ↗
September 22, 2026
Via The Motley Fool
News headline image
Novo's CEO Called Ozempic's Patent Cliff the "Elephant in the Room" Yesterday. Is the Stock Still a Buy? ↗
September 22, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Novo Nordisk Targets Five Multi-Blockbusters by 2030 as Oral Wegovy Gains Traction ↗
September 21, 2026
Via MarketBeat
News headline image
Why Novo Nordisk Stock Just Crashed ↗
September 21, 2026
Via The Motley Fool
News headline image
Wall Street Sees a Huge Rebound for Viking Therapeutics. Here's Why Analysts Are So Optimistic. ↗
September 17, 2026
Via The Motley Fool
News headline image
This Trend is Excellent News for Eli Lilly and Its Investors ↗
September 17, 2026
Via The Motley Fool
News headline image
Where Will Novo Nordisk Be in 5 Years as the GLP-1 Market Gets More Crowded? ↗
September 16, 2026
Via The Motley Fool
Topics Economy
News headline image
Eli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change Everything ↗
September 15, 2026
Via The Motley Fool
News headline image
3 Absurdly Cheap Growth Stocks to Buy Before the End of 2026 ↗
September 15, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 15, 2026
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 37.40
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 10/01/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap